for enquiries or appointments
Serangoon Garden

HIV Testing / Screening

Types of HIV Tests Available(Anonymous HIV Testing available)
Time from Exposure
Time to results
Fees (before GST)
Less than 3 days or 72 hours
No testing is available at this stage.
You may wish to consider HIV PEP (Post Exposure Prophylaxis) if you have had a high risk exposure, i.e. unprotected sex with a commercial sex worker or high risk contact, or needlestick injury from a IV drug abuser.
HIV PEP was shown to be >80% effective in reducing risk of HIV infection. In animal studies, it was shown that the earlier (
10 - 14 days
HIV RNA/DNA Polymerase Chain Reaction (PCR) Test
1 - 2 weeks
21 - 28 days
(3 - 4 weeks)
Rapid Fingerprick Blood HIV-1/2 P24 Antigen/Antibody Combo (HIV Duo Test) (4th generation)
20 min
Recommended by UK Guidelines in HIV Testing 2008 - conclusive at 28 days post exposure.
More than 28 days (> 4 weeks)
HIV Antibody Test (ELISA)

Rapid Oral Saliva HIV-1/2 Antibody Test (Oraquick)

Rapid Fingerprick Blood HIV-1/2 Antibody Test (Determine)
1 - 3 days

20 min

20 min


Results are 90% accurate at 1 month post exposure
Results are >99% accurate at 3 months post exposure
Anonymous HIV Testing

Kensington Family Clinic is an approved Anonymous HIV Testing Site, licensed by the Ministry of Health Singapore. If you wish to do anonymous HIV Testing, simply mention "AHT", or anonymous testing and our staff will know what to do. No names, no identification and no registration details required.

What is HIV Testing/Screening?

Depending on your sexual exposure and time from exposure, different HIV screening tests may be required or recommended. Sexual exposure refers to any type of sexual contact e.g. oral, vaginal or anal intercourse with a high risk contact such as a commercial sex worker or people with risky sexual behaviour. Use of barrier protection methods such as condoms greatly reduces your risk but it is not 100%. There is always a risk whenever there is skin or mucosal contact with HIV-contaminated genital fluids or blood.

What are HIV symptoms?

Unfortunately, HIV is frequently asymptomatic ( that is, it displays no symptoms ) until the late stages, where AIDS ( Acquired Immunodeficiency Syndrome ) may already be evident.

Early symptoms may occur, usually within 1 to 4 weeks of infection. This is termed seroconversion illness and typically presents with flu-like symptoms, such as fever, bodyaches, swollen neck glands and running nose. These symptoms subside, even without treatment, in a few weeks.

As the infection progresses and the immune system weakens, other symptoms may subsequently appear. The time taken for this to occur may stretch as long as 10 years, or even more.

The later symptoms may include :-
  • Lack of energy and tiredness
  • Weight loss
  • Fever or night sweats
  • Persistent or unusual skin rashes
  • Recurrent and severe flare-ups of herpes
  • Recurrent and severe yeast or fungal infections
  • Cough or shortness of breath
  • Seizures and lack of coordination
  • Difficult or painful swallowing
  • Mental symptoms such as confusion and forgetfulness
  • Severe and persistent diarrhea
  • Vision loss

As patients with HIV progresses into full blown AIDS, they also become prone to developing various cancers such as Kaposi sarcoma ( a type of skin cancer ), cervical cancer and lymphomas ( cancers of the immune system ). With AIDS, the survival time if no treatment is given has been estimated to be 2-3 years on average.

What is the risk of getting infected with HIV?
  1. From the US CDC ( Centers for Disease Control and Prevention ) website
    Estimated Per-Act Probability of Acquiring HIV from an Infected Source, by Exposure Acta
    Exposure route
    Risk per 10,000 exposures
    Estimated Risks
    Blood Transfusion
    ~1 in 1
    Needle-sharing injection-drug use
    ~ 1 in 150
    Percutaneous needle stick
    ~ 1 in 300
    Receptive anal intercourse
    ~ 1 in 200
    Receptive penile-vaginal intercourse
    ~ 1 in 1000
    Insertive anal intercourse
    ~ 1 in 1500
    Insertive penile-vaginal intercourse
    ~ 1 in 2000
    Receptive oral intercourse
    ~ 1 in 10000
    Insertive oral intercourse
    ~ 1 in 20000

    1. Factors that increase the risk of HIV transmission include sexually transmitted infections, early and late-stage HIV infection, and a high level of HIV in the blood.
      Factors that reduce the risk of HIV transmission include condom use, male circumcision, and use of antiretrovirals.
    2. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113(10):733-739.
    3. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992;5(11):1116-1118.
    4. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997;102(5B):9-15.
    5. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002;29(1):38-43.
    6. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304(6830):809-813.
    7. Leynaert B, Downs AM, de Vincenzi I; European Study Group on Heterosexual Transmission of HIV. Heterosexual transmission of HIV: variability of infectivity throughout the course of infection. Am J Epidemiol 1998;148(1):88-96.
    8. HIV transmission through these exposure routes is technically possible but extremely unlikely and not well documented.
    9. HIV transmission through oral sex has been documented, but rare. Accurate estimates of risk are not available.
    10. Pretty LA, Anderson GS, Sweet DJ. Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999;20(3):232-239.
  2. From the Canadian AIDS Treatment Information Exchange:

    Risk of HIV Transmission From Different Types of Unprotected Sex
    Number of Individual Studies
    Range of Estimates
    Meta-Analysis Estimate
    Receptive anal
    Insertive anal
    Receptive vaginal
    Insertive vaginal
  3. From this UK-based patient information website, NAM ( National AIDS Manual ):
    Estimated HIV transmission risk per exposure for specific activities and events
    Vaginal sex, male-to-female, studies in high-income countries
    0.04% (1:2380)
    Vaginal sex, female-to-male, studies in low-income countries
    0.08% (1:1234)
    Vaginal sex, male-to-female, studies in low-income countries
    0.38% (1:263)
    Vaginal sex, male-to-female, source partner is asymptomatic
    0.30% (1:333)
    Vaginal sex, male-to-female, source partner has late-stage disease
    0.07% (1:1428)
    Receptive anal sex amongst gay men, partner unknown status
    0.55% (1:180)
    Receptive anal sex amongst gay men, partner HIV positive
    0.27% (1:370)
    Receptive anal sex with condom, gay men, partner unknown status
    0.82% (1:123)
    Insertive anal sex, gay, partner unknown status
    0.18% (1:555)
    Insertive anal sex with condom, gay men, partner unknown status
    0.06% (1:1666)
    Receptive fellatio
    Estimatesrange from 0.00% t0 0.04% (1:2500)
    Mother-to-child, mother takes at least two weeks antiretroviral therapy
    0.08% (1:125)
    Mother-to-child, mother takes combination therapy, viral load below 50
    0.01% (1:1000)
    Injecting drug use
    Estimates range from 0.63% (1:158) to 2.4% (1:41)
    Needlestick injury, no other risk factors
    0.13% (1:769)
    Blood transfusion with contaminated blood
    92.5% (9:10)

    Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5

    1. Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
    2. Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
    3. Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
    4. Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
    5. Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
    Risk Category
    Type of Exposure ( assuming partner is HIV positive )
    Very high risk
    Blood transfusion of infected blood

    Needle sharing amongst IV drug users

    Receptive anal sex


    0.4% - 3.38%
    Moderate to high risk
    Receptive vaginal sex

    Insertive anal sex

    Insertive vaginal sex
    0.08% to 0.19%

    0.06% - 0.62%

    0.03% - 0.1%
    Low risk
    Receptive oral sex
    Extremely rare
    Negligible / Theoretical risk

    ( theoretically possible but extremely unlikely and no well-documented cases )
    Insertive oral sex

    'Rimming' / Peri-anal licking

    Sharing sex toys



    Throwing body fluids eg. semen/saliva
    No documented cases; carries risk of other STIs if unprotected

    Carries risk of other STIs

    Carries risk of other STIs

    Risk of wound infection
    Factors which increase the risk
    Presence of a concomitant STI

    Presence of sores or wounds or ulcers

    High viral load in partner

    Presence of ejaculation ( for receptive partner )


    0.4% - 3.38%
    Factors which reduce the risk
    Anti-retroviral ( ARV ) treatment in affected partner

    Consistent and correct condom use

    Male circumcision
    96% reduction(1)

    80% reduction(2)

    50-60% reduction ( female-to-male )

    1. Cohen MS, Chen YQ, McCauley M, et al; HPTN 052 Study Team. Prevention of HIV-1 Infection with early antiretroviral therapy. N Engl J Med2011;365(6):493-505.
    2. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission (Review). The Cochrane Collaboration. Wiley and Sons, 2011.

What happens if my HIV test is positive?

If the initial screening test is positive, a second blood sample will need to be sent for a confirmatory test called the Western Blot. This test typically takes about 2 weeks to be ready. No fasting or other special preparation is required.

The Western Blot may show:
  • Negative ( good news! But consider repeating antibody test in 3 months if there has been risk of exposure )
  • Indeterminate ( Consider repeating antibody test or P24 Combo test in 1 month if there has been risk of exposure )
  • Positive ( Our doctor will discuss the subsequent options for treatment and follow up with you ). If the Western Blot confirms the presence of HIV infection, you will be referred to the Communicable Disease Centre ( of Singapore ) for further management. Alternative centres for treatment are also available in the major tertiary hospitals in Singapore. It is important that you understand relatively effective medications are available for the control of HIV. The key to obtaining a better outcome is to seek treatment and follow-up early.

At Kensington Family Clinic, HIV testing is fully anonymous. No names or registration details are required, even if you are tested positive on confirmatory Western Blot testing.

HIV is certainly a serious infection, but options now exist for patients to have the infection suppressed and controlled. This can help reduce or delay the late complications of HIV infection and help protect your sexual contacts from HIV. Therefore it is crucial to take the first step and be tested.